Varaico: Literature-Extracted Genetic Variants

Gene:NRAS
Variant:p.I24N
Back to variants list

NRAS

NM_002524.5:p.I24N

Associated Papers

Identification and analysis of oncogenic non-synonymous single nucleotide polymorphisms in the human NRAS gene: An exclusive in silico study.

Mozibullah M et al.

Journal, Genetic Engineering & Biotechnology, 2024

38797553 (PubMed )
Supplement: mmc1.xlsx › Table_1

Identification of NRAS Diagnostic Biomarkers and Drug Targets for Endometrial Cancer-An Integrated in Silico Approach.

Alessandro L et al.

International Journal of Molecular Sciences, 2022

Are transient protein-protein interactions more dispensable?

Ghadie MA et al.

Plos Computational Biology, 2022

35404956 (PubMed )
Supplement: pcbi.1010013.s002.xlsx › _B__Y2H-SI_disMut_edgotypes

The RASopathies: from pathogenetics to therapeutics.

Hebron KE et al.

Disease Models & Mechanisms, 2022

Duplications in the G3 domain or switch II region in HRAS identified in patients with Costello syndrome.

Nagai K et al.

Human Mutation, 2022

Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer.

Loree JM et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2021

The early evolutionary landscape of osteosarcoma provides clues for targeted treatment strategies.

Kovac M et al.

The Journal of Pathology, 2021

Structural bioinformatics enhances mechanistic interpretation of genomic variation, demonstrated through the analyses of 935 distinct RAS family mutations.

Tripathi S et al.

Bioinformatics (oxford, England), 2021

33226070 (PubMed )
Supplement: btaa972_supplementary_data.zip › TableS2_RAS_Variants_CompScores.xlsx › Sheet_1

Mutation Edgotype Drives Fitness Effect in Human.

Ghadie M et al.

Frontiers in Bioinformatics, 2021

36303776 (PubMed )
Supplement: Table2.XLSX › _B__Y2H-SI_pathMt_edgotype

SOS GEFs in health and disease.

Baltanás FC et al.

Biochimica Et Biophysica Acta. Reviews on Cancer, 2020

Development of Noonan syndrome by deregulation of allosteric SOS autoactivation.

Umutesi HG et al.

The Journal of Biological Chemistry, 2020

Germline and sporadic cancers driven by the RAS pathway: parallels and contrasts.

Dunnett-Kane V et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology, 2020

Swimming toward solutions: Using fish and frogs as models for understanding RASopathies.

Patterson VL et al.

Birth Defects Research, 2020

The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway.

Tajan M et al.

Endocrine Reviews, 2018

Genotype and phenotype spectrum of NRAS germline variants.

Altmüller F et al.

European Journal of Human Genetics : Ejhg, 2017

Juvenile myelomonocytic leukemia-associated variants are associated with neo-natal lethal Noonan syndrome.

Mason-Suares H et al.

European Journal of Human Genetics : Ejhg, 2017

Mutation in NRAS in familial Noonan syndrome--case report and review of the literature.

Ekvall S et al.

Bmc Medical Genetics, 2015

Constitutional NRAS mutations are rare among patients with Noonan syndrome or juvenile myelomonocytic leukemia.

Kraoua L et al.

American Journal of Medical Genetics. Part A, 2012

NRAS Mutations in Noonan Syndrome.

Denayer E et al.

Molecular Syndromology, 2012

Noonan syndrome gain-of-function mutations in NRAS cause zebrafish gastrulation defects.

Runtuwene V et al.

Disease Models & Mechanisms, 2011

1p13.2 deletion displays clinical features overlapping Noonan syndrome, likely related to NRAS gene haploinsufficiency.

Linhares ND et al.

Genetics and Molecular Biology, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."